YF
SGMT icon

Yu Fan’s Sagimet Biosciences SGMT Stock Holding History

Yu Fan’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,190
Closed -$186K – 9
2025
Q1 		$186K Hold
57,190
– – 0.19% 8
2024
Q4 		$257K Hold
57,190
– – 0.48% 6
2024
Q3 		$158K Hold
57,190
– – 0.49% 6
2024
Q2 		$196K Hold
57,190
– – 0.26% 6
2024
Q1 		$310K Hold
57,190
– – 0.43% 4
2023
Q4 		$310K Hold
57,190
– – 1.55% 3
2023
Q3 		$503K Buy
+57,190
New +$761K 35.7% 1

Other funds holding SGMT

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

Yu Fan's SGMT Position: Q2 2025 in Review

Yu Fan sold out of Sagimet Biosciences (SGMT) in Q2 2025, closing a stake of 57,190 shares — an estimated $186K sold.

Yu Fan first reported a position in SGMT in Q3 2023 and held it in 7 quarters. The position peaked at $503K in Q3 2023. 67 funds tracked by Wall St. Rank hold SGMT as of Q2 2025.

  • Yu Fan reported no remaining Sagimet Biosciences position as of Q2 2025 after selling out during the quarter.
  • Yu Fan sold 57,190 Sagimet Biosciences shares in Q2 2025, an estimated $186K.
  • Yu Fan first reported a position in Sagimet Biosciences in Q3 2023 and held it in 7 quarters.
  • Yu Fan's Sagimet Biosciences position peaked at $503K in Q3 2023.
  • 67 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2025.

Based on Yu Fan's 13F filing for Q2 2025, filed 14 Aug 2025.